Senior Statistician, Early Development
Genentech
Summary
The Early Development Statistician helps shape the early clinical narrative by ensuring data are robust, interpretable, and aligned with the evolving development strategy.
Job description
The Opportunity
The Early Development Statistician helps shape the early clinical narrative by ensuring data are robust, interpretable, and aligned with the evolving development strategy.
Key Responsibilities
- Contribute to early phase trial design under guidance, leveraging standard and adaptive methods for small samples and exploratory objectives, e.g., dose escalation models and Bayesian approaches
- Draft and review protocols, SAPs, and CRFs using established templates, ensuring alignment with early development goals such as pharmacokinetics, pharmacodynamics, and early efficacy signals
- Perform or support statistical analyses per SAPs, often with non-traditional endpoints or biomarkers, and proactively flag data anomalies or design-related challenges
- Collaborate with study teams to meet deliverables on accelerated timelines
- Summarize findings clearly, translating complex outputs into concise insights that inform early go/no-go decisions or subsequent phase designs
- Contribute to clinical study reports and regulatory submissions, supporting documentation for INDs, EMA scientific advice, and FDA pre-IND meetings
- Apply judgment to solve moderately complex statistical or data issues, balancing rigor with flexibility needed in early phase development
- Adhere to functional standards and participate in peer review and mentoring
- Work under general supervision and apply independent judgment to interpret guidance, prioritize responsibilities, and make decisions
Who You Are
- MSc or PhD in Statistics, Biostatistics, or a closely related quantitative field
- At least 3 years of relevant experience (with a PhD) or 4 years of experience (with an MSc) in clinical trial statistics within pharmaceutical, biotech, or CRO settings
- Familiar with ICH guidelines, GCP, and regulatory requirements such as FDA and EMA
- Strong understanding of statistical principles and methodologies relevant to clinical trial design and analysis
- Proficient in SAS and/or R and familiar with CDISC standards
Preferred
- Experience working in cross-functional global study teams, including Clinical Pharmacology, Translational Medicine, and Early Clinical Development
- Effective communication skills with the ability to translate complex statistical concepts for non-statistical audiences
- Basic understanding of multiple phases of drug development, with emphasis on early-phase (Phase I/II) design and analysis, including first-in-human, SAD/MAD, and proof-of-concept studies
- Experience within a matrixed early development environment
- Familiarity with innovative design methods (e.g., Bayesian designs, model-informed drug development) and regulatory expectations for exploratory endpoints
- Agility and comfort working with incomplete or evolving data
Requirements
- MSc or PhD in Statistics, Biostatistics, or a closely related quantitative field
- At least 3 years of relevant experience (with a PhD) or 4 years of experience (with an MSc) in clinical trial statistics within pharmaceutical, biotech, or CRO settings
- Familiar with ICH guidelines, GCP, and regulatory requirements such as FDA and EMA
- Strong understanding of statistical principles and methodologies relevant to clinical trial design and analysis
- Proficient in SAS and/or R
- Familiar with CDISC standards
Benefits
- Discretionary annual bonus
- Health benefits
Company overview
Genentech, founded in 1976 and now a member of the Roche Group, is widely recognized as the pioneer of the biotechnology industry. The company has been at the forefront of scientific innovation for nearly 50 years, using human genetic information to develop novel medicines for serious and life-threatening diseases. Genentech's transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis. With over 10,000 employees, the company operates from its South San Francisco headquarters and maintains a strong focus on oncology, immunology, neuroscience, ophthalmology, and infectious diseases. Genentech continues to pursue groundbreaking science while maintaining its startup spirit within the Roche organization, consistently delivering on its promise to improve patients' lives through innovative biopharmaceutical solutions.